ACADIA Pharmaceuticals Inc. Common Stock is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to address unmet medical needs in central nervous system disorders. With a strong pipeline and a commitment to research and development, ACADIA is poised to make significant contributions to the field of neuroscience.
Notification